EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| ChEBI ID | CHEBI:139512 |
| ChEBI Name | EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor |
| Stars | |
| Definition | An EC 1.3.1.* (oxidoreductase acting on donor CH-CH group, NAD+ or NADP+ as acceptor) inhibitor that interferes with the action of enoyl-[acyl-carrier-protein] reductase (NADH), EC 1.3.1.9. |
| Last Modified | 6 May 2020 |
| Submitter | Steve |
| Wikipedia |
|---|
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor (CHEBI:139512) is a EC 1.3.1.* (oxidoreductase acting on donor CH-CH group, NAD+ or NADP+ as acceptor) inhibitor (CHEBI:76857) |
| Incoming Relation(s) |
| atromentin (CHEBI:149660) has role EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor (CHEBI:139512) |
| triclosan (CHEBI:164200) has role EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor (CHEBI:139512) |
| Synonyms | Source |
|---|---|
| NADH-specific enoyl-ACP reductase inhibitor | ChEBI |
| acyl-[acyl-carrier-protein]:NAD+ oxidoreductase inhibitors | ChEBI |
| NADH-enoyl acyl carrier protein reductase inhibitor | ChEBI |
| enoyl-[acyl carrier protein] reductase inhibitors | ChEBI |
| enoyl-ACP reductase inhibitor | ChEBI |
| acyl-[acyl-carrier-protein]:NAD+ oxidoreductase inhibitor | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| Enoyl-acyl_carrier_protein_reductase | Wikipedia |